- recruitingNA
Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules
This study looks at a new treatment called Thyroid Artery Embolization (TAE) for large, non-cancerous lumps in the throat (thyroid nodules) or overactive thyroids. It's a small study in the UK to see if TAE is safe and to gather शुरुआती information.
United Kingdom - authorisedHuman Pharmacology (Phase I)- First administration to humans
A study to test single and multiple doses of MER511 given to adults with Graves’ disease
This study is looking into a new medicine, MER511, for people with an overactive thyroid caused by Graves' disease. It will test how safe the medicine is and how it works in the body when given in different doses, for the very first time in people.
Spain - recruitingPHASE2
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
This study is testing a new medicine, rilzabrutinib, for adults with an overactive thyroid caused by Graves' disease, including those with eye problems. We want to see how well it works and if it's safe at two different doses.
Canada · Germany · Italy - recruitingPHASE2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
This study is looking for adults with Graves' disease whose thyroid is overactive despite medication. It aims to see if a new medicine, IMVT-1402, is safe and helps control their thyroid better than a dummy medicine. We want to find a better treatment.
United States · Australia · Brazil - recruitingPHASE2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
This study is testing a new medicine, IMVT-1402, for adults with Graves' disease whose thyroid is still overactive despite current treatment. We want to see if it works, is safe, and is well-tolerated. It's a Phase 2 trial. You can find out more if you're interested.
United States · Belgium · Georgia